| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | spectrin binding | 2.65e-05 | 34 | 102 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 5.63e-05 | 15 | 102 | 3 | GO:0051011 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 1.12e-06 | 38 | 101 | 5 | GO:0007026 | |
| GeneOntologyBiologicalProcess | neuromuscular process controlling balance | 1.68e-06 | 74 | 101 | 6 | GO:0050885 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 1.88e-06 | 42 | 101 | 5 | GO:0031114 | |
| GeneOntologyBiologicalProcess | microtubule-based process | KAT5 CNTRL GTSE1 CAMSAP3 APC KIAA1614 CCNB1 FSIP2 NCOR1 ATXN7 VANGL1 SYNE2 H1-6 KATNIP CAMSAP1 CAMSAP2 ARHGAP21 CEP19 | 3.43e-06 | 1058 | 101 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 5.01e-06 | 51 | 101 | 5 | GO:0031111 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 1.80e-05 | 66 | 101 | 5 | GO:0007019 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | KAT5 CNTRL CAMSAP3 APC KIAA1614 CCNB1 FSIP2 NCOR1 ATXN7 SYNE2 CAMSAP1 CAMSAP2 CEP19 | 4.95e-05 | 720 | 101 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | negative regulation of animal organ morphogenesis | 7.10e-05 | 3 | 101 | 2 | GO:0110111 | |
| GeneOntologyBiologicalProcess | negative regulation of odontogenesis | 7.10e-05 | 3 | 101 | 2 | GO:0042483 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 7.64e-05 | 89 | 101 | 5 | GO:1901880 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 7.82e-05 | 284 | 101 | 8 | GO:0007626 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.33e-04 | 100 | 101 | 5 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.67e-04 | 105 | 101 | 5 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 1.91e-04 | 108 | 101 | 5 | GO:0031110 | |
| GeneOntologyBiologicalProcess | regulation of attachment of spindle microtubules to kinetochore | 2.14e-04 | 24 | 101 | 3 | GO:0051988 | |
| GeneOntologyBiologicalProcess | adult locomotory behavior | 2.66e-04 | 116 | 101 | 5 | GO:0008344 | |
| GeneOntologyBiologicalProcess | cytoplasmic microtubule organization | 3.09e-04 | 66 | 101 | 4 | GO:0031122 | |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 3.67e-04 | 69 | 101 | 4 | GO:0031113 | |
| GeneOntologyBiologicalProcess | positive regulation of chromosome segregation | 3.80e-04 | 29 | 101 | 3 | GO:0051984 | |
| GeneOntologyCellularComponent | microtubule minus-end | 4.01e-06 | 7 | 103 | 3 | GO:0036449 | |
| GeneOntologyCellularComponent | adherens junction | 8.69e-05 | 212 | 103 | 7 | GO:0005912 | |
| Domain | CAMSAP_CKK | 1.63e-07 | 3 | 103 | 3 | PF08683 | |
| Domain | CAMSAP_CC1 | 1.63e-07 | 3 | 103 | 3 | IPR031372 | |
| Domain | CAMSAP_CC1 | 1.63e-07 | 3 | 103 | 3 | PF17095 | |
| Domain | CAMSAP | 1.63e-07 | 3 | 103 | 3 | IPR032940 | |
| Domain | CAMSAP_CKK | 1.63e-07 | 3 | 103 | 3 | SM01051 | |
| Domain | CKK | 1.63e-07 | 3 | 103 | 3 | PS51508 | |
| Domain | PRC_barrel-like | 1.63e-07 | 3 | 103 | 3 | IPR011033 | |
| Domain | CKK_domain | 1.63e-07 | 3 | 103 | 3 | IPR014797 | |
| Domain | CAMSAP_CH | 5.61e-06 | 7 | 103 | 3 | PF11971 | |
| Domain | CAMSAP_CH | 5.61e-06 | 7 | 103 | 3 | IPR022613 | |
| Domain | DUF4599 | 3.46e-05 | 12 | 103 | 3 | PF15371 | |
| Domain | DUF4599 | 3.46e-05 | 12 | 103 | 3 | IPR027970 | |
| Domain | CH | 7.09e-04 | 73 | 103 | 4 | PS50021 | |
| Domain | CH-domain | 7.85e-04 | 75 | 103 | 4 | IPR001715 | |
| Domain | RhoGAP | 4.87e-03 | 62 | 103 | 3 | SM00324 | |
| Domain | RhoGAP | 5.09e-03 | 63 | 103 | 3 | PF00620 | |
| Domain | RHOGAP | 5.32e-03 | 64 | 103 | 3 | PS50238 | |
| Domain | RhoGAP_dom | 5.32e-03 | 64 | 103 | 3 | IPR000198 | |
| Domain | - | 5.32e-03 | 64 | 103 | 3 | 1.10.555.10 | |
| Pubmed | SFMBT1 IRS4 CAMSAP3 APC INPP5F DENND4C PRDM2 NCOR1 ZZZ3 ZNF644 ANKRD17 CAMSAP1 ARHGAP21 | 4.66e-10 | 418 | 105 | 13 | 34709266 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | IRS4 GTSE1 CAMSAP3 APC INPP5F GLCCI1 DENND4C FSIP2 SYNE2 OTUD7A RAB11FIP5 ANKRD17 TANC1 CAMSAP1 CAMSAP2 ARHGAP21 WNK3 | 9.02e-10 | 861 | 105 | 17 | 36931259 |
| Pubmed | IRS4 ELOA2 CNTRL UTP14A CAMSAP3 C2orf78 RYBP BPTF ZC3H7A NCOR1 ATXN7 EFCAB12 SYNE2 H1-6 TMPO HADHA NGLY1 EMC2 CAMSAP2 ARHGAP21 | 1.08e-08 | 1442 | 105 | 20 | 35575683 | |
| Pubmed | Regulation of microtubule minus-end dynamics by CAMSAPs and Patronin. | 2.67e-08 | 3 | 105 | 3 | 24706919 | |
| Pubmed | The CKK domain (DUF1781) binds microtubules and defines the CAMSAP/ssp4 family of animal proteins. | 2.67e-08 | 3 | 105 | 3 | 19508979 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | SFMBT1 NCAPD3 KAT5 HIPK1 GTSE1 UTP14A FARSB REV3L BLM BPTF IRF9 NCOR1 ZNF644 ANKRD17 CAMSAP1 | 4.71e-08 | 857 | 105 | 15 | 25609649 |
| Pubmed | NCAPD3 ELOA2 MYO7A FARSB REV3L MEPE ANKRD36B NCOR1 ATXN7 SYNE2 RAB11FIP5 ANKRD17 CTNND2 | 7.04e-08 | 638 | 105 | 13 | 31182584 | |
| Pubmed | CACNA1A HIPK1 SYTL2 CAMSAP3 APC GLCCI1 ADCY9 KCNMA1 RAB11FIP5 CTNND2 | 1.07e-07 | 347 | 105 | 10 | 17114649 | |
| Pubmed | CACNA1A CACNB2 ARHGAP24 CAMSAP3 APC FARSB NCOR1 SYNE2 KCNMA1 ANKRD17 CTNND2 CAMSAP1 CAMSAP2 ARHGAP21 WNK3 | 2.12e-07 | 963 | 105 | 15 | 28671696 | |
| Pubmed | Wdr47, Camsaps, and Katanin cooperate to generate ciliary central microtubules. | 2.66e-07 | 5 | 105 | 3 | 34608154 | |
| Pubmed | Microtubule minus-end stabilization by polymerization-driven CAMSAP deposition. | 2.66e-07 | 5 | 105 | 3 | 24486153 | |
| Pubmed | NCAPD3 ZNF346 KAT5 UTP14A PHRF1 CAMSAP3 APC FARSB BLM ZC3H7A FGD4 ATXN7 VANGL1 ANKRD17 CRYBG1 TANC1 CTNND2 CAMSAP2 | 5.30e-07 | 1497 | 105 | 18 | 31527615 | |
| Pubmed | Identification of a novel Sry-related gene and its germ cell-specific expression. | 5.31e-07 | 6 | 105 | 3 | 10359848 | |
| Pubmed | 6.58e-07 | 101 | 105 | 6 | 10997877 | ||
| Pubmed | 1.42e-06 | 263 | 105 | 8 | 34702444 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SFMBT1 NCAPD3 KAT5 RNF168 PHRF1 PRDM2 BLM RYBP BPTF NCOR1 ZZZ3 ZNF644 H1-6 TMPO HADHA NAIF1 | 1.71e-06 | 1294 | 105 | 16 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCAPD3 GTSE1 PHRF1 CAMSAP3 PRDM2 BLM BPTF NCOR1 ATXN7 ZNF644 TMPO ANKRD17 | 4.00e-06 | 774 | 105 | 12 | 15302935 |
| Pubmed | SFMBT1 CNTRL UTP14A APC ADCY9 BLM NCOR1 VANGL1 TMPO RAB11FIP5 CAMSAP1 ARHGAP21 | 4.16e-06 | 777 | 105 | 12 | 35844135 | |
| Pubmed | CAMSAP1 breaks the homeostatic microtubule network to instruct neuronal polarity. | 5.77e-06 | 12 | 105 | 3 | 32839317 | |
| Pubmed | KAT5 ZNF212 PHRF1 REV3L RNF43 ADCY9 BPTF ZZZ3 ATXN7 VANGL1 RAB11FIP5 ANKRD17 TANC1 SEZ6L | 6.87e-06 | 1116 | 105 | 14 | 31753913 | |
| Pubmed | Mutation analysis of the MYO7A and CDH23 genes in Japanese patients with Usher syndrome type 1. | 9.03e-06 | 2 | 105 | 2 | 20844544 | |
| Pubmed | IRF9 and XAF1 as Diagnostic Markers of Primary Sjogren Syndrome. | 9.03e-06 | 2 | 105 | 2 | 36132546 | |
| Pubmed | CAMSAP3 maintains neuronal polarity through regulation of microtubule stability. | 9.03e-06 | 2 | 105 | 2 | 30190432 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 37567766 | ||
| Pubmed | CAMSAPs organize an acentrosomal microtubule network from basal varicosities in radial glial cells. | 9.03e-06 | 2 | 105 | 2 | 34019079 | |
| Pubmed | Cancer predisposition caused by elevated mitotic recombination in Bloom mice. | 9.03e-06 | 2 | 105 | 2 | 11101838 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 14648237 | ||
| Pubmed | [Usher type I syndrome in children: genotype/phenotype correlation and cochlear implant benefits]. | 9.03e-06 | 2 | 105 | 2 | 18323324 | |
| Pubmed | Cdh23 mutations in the mouse are associated with retinal dysfunction but not retinal degeneration. | 9.03e-06 | 2 | 105 | 2 | 14609561 | |
| Pubmed | Enhanced tumor formation in mice heterozygous for Blm mutation. | 9.03e-06 | 2 | 105 | 2 | 12242442 | |
| Pubmed | Stereocilia defects in waltzer (Cdh23), shaker1 (Myo7a) and double waltzer/shaker1 mutant mice. | 9.03e-06 | 2 | 105 | 2 | 12121736 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23169647 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 32482850 | ||
| Pubmed | Cadherin 23-C Regulates Microtubule Networks by Modifying CAMSAP3's Function. | 9.03e-06 | 2 | 105 | 2 | 27349180 | |
| Pubmed | APC FARSB ADCY9 DENND4C VANGL1 TMPO RAB11FIP5 ANKRD17 HADHA CAMSAP1 ARHGAP21 | 1.01e-05 | 708 | 105 | 11 | 39231216 | |
| Pubmed | 1.46e-05 | 16 | 105 | 3 | 17567809 | ||
| Pubmed | IRS4 CAMSAP3 ADCY9 BLM NCOR1 GTF2E1 VANGL1 SYNE2 KCNMA1 TMPO RAB11FIP5 TANC1 HADHA | 1.71e-05 | 1049 | 105 | 13 | 27880917 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 2.11e-05 | 184 | 105 | 6 | 32908313 | |
| Pubmed | SKP1 drives the prophase I to metaphase I transition during male meiosis. | 2.50e-05 | 19 | 105 | 3 | 32232159 | |
| Pubmed | IRS4 KAT5 UTP14A PRDM2 BLM RYBP BPTF IRF9 NCOR1 ZZZ3 ATXN7 ZNF644 SYNE2 ANKRD17 HADHA | 2.58e-05 | 1429 | 105 | 15 | 35140242 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 23426693 | ||
| Pubmed | Genetic analysis through OtoSeq of Pakistani families segregating prelingual hearing loss. | 2.70e-05 | 3 | 105 | 2 | 23770805 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 17050716 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 16679490 | ||
| Pubmed | Loss of CAMSAP3 promotes EMT via the modification of microtubule-Akt machinery. | 2.70e-05 | 3 | 105 | 2 | 30282632 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 14578428 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 20639393 | ||
| Pubmed | HIV-1 Tat impairs cell cycle control by targeting the Tip60, Plk1 and cyclin B1 ternary complex. | 2.70e-05 | 3 | 105 | 2 | 22391203 | |
| Pubmed | Tip60 acetyltransferase activity is controlled by phosphorylation. | 2.70e-05 | 3 | 105 | 2 | 12468530 | |
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 27034204 | ||
| Pubmed | 2.70e-05 | 3 | 105 | 2 | 26527747 | ||
| Pubmed | The anatomy and development of the mutants pirouette, shaker-1 and waltzer in the mouse. | 2.70e-05 | 3 | 105 | 2 | 13336002 | |
| Pubmed | Clinical and genetic findings in an Ashkenazi Jewish population with colorectal neoplasms. | 2.70e-05 | 3 | 105 | 2 | 15959913 | |
| Pubmed | Downregulation of circ-ZNF644 alleviates LPS-induced HK2 cell injury via miR-335-5p/HIPK1 axis. | 2.70e-05 | 3 | 105 | 2 | 36052886 | |
| Pubmed | NCAPD3 ZNF212 PHRF1 DOLK INPP5F KIAA1614 ADCY9 RAB11FIP5 ANKRD17 | 3.36e-05 | 529 | 105 | 9 | 14621295 | |
| Pubmed | 4.30e-05 | 209 | 105 | 6 | 36779422 | ||
| Pubmed | 4.49e-05 | 128 | 105 | 5 | 30995482 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 16481439 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 32633323 | ||
| Pubmed | 5.40e-05 | 4 | 105 | 2 | 25869926 | ||
| Pubmed | 6.01e-05 | 222 | 105 | 6 | 37071664 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 6.27e-05 | 444 | 105 | 8 | 34795231 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 7.56e-05 | 588 | 105 | 9 | 38580884 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 12588794 | ||
| Pubmed | Interactions in the network of Usher syndrome type 1 proteins. | 8.97e-05 | 5 | 105 | 2 | 15590703 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 20332152 | ||
| Pubmed | Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population. | 8.97e-05 | 5 | 105 | 2 | 15660226 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 16787652 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 16219682 | ||
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 22381527 | ||
| Pubmed | A Cdh1-FoxM1-Apc axis controls muscle development and regeneration. | 8.97e-05 | 5 | 105 | 2 | 32152291 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 11804332 | ||
| Pubmed | Spinocerebellar ataxias: microsatellite and allele frequency in unaffected and affected individuals. | 8.97e-05 | 5 | 105 | 2 | 20069235 | |
| Pubmed | 8.97e-05 | 5 | 105 | 2 | 12485990 | ||
| Pubmed | SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice. | 9.53e-05 | 150 | 105 | 5 | 30154076 | |
| Pubmed | 9.58e-05 | 472 | 105 | 8 | 38943005 | ||
| Pubmed | Genome-wide association study of lung function decline in adults with and without asthma. | 1.24e-04 | 32 | 105 | 3 | 22424883 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO7A GTSE1 MDFI REV3L RNF43 ADCY9 HIVEP3 NCOR1 KCNK5 TANC1 CAMSAP1 ARHGAP21 | 1.29e-04 | 1105 | 105 | 12 | 35748872 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 1.31e-04 | 256 | 105 | 6 | 33397691 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 20850414 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 26620972 | ||
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 16389595 | ||
| Pubmed | LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis. | 1.34e-04 | 6 | 105 | 2 | 30224759 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 14767162 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 1.34e-04 | 6 | 105 | 2 | 25930072 | |
| Pubmed | 1.34e-04 | 6 | 105 | 2 | 10328888 | ||
| Pubmed | 1.44e-04 | 87 | 105 | 4 | 12465718 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ZNF346 IRS4 GTSE1 UTP14A FARSB BLM BPTF NCOR1 ZZZ3 ZNF644 TMPO | 1.49e-04 | 954 | 105 | 11 | 36373674 |
| Pubmed | ATRX proximal protein associations boast roles beyond histone deposition. | 1.71e-04 | 91 | 105 | 4 | 34780483 | |
| Pubmed | Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes. | 1.88e-04 | 7 | 105 | 2 | 15572405 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 20301442 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 32320668 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 18281465 | ||
| Pubmed | Planar cell polarity induces local microtubule bundling for coordinated ciliary beating. | 1.88e-04 | 7 | 105 | 2 | 33929515 | |
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 21436032 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 13853422 | ||
| Pubmed | 1.88e-04 | 7 | 105 | 2 | 30108230 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 2.26e-04 | 283 | 105 | 6 | 30585729 | |
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 2.50e-04 | 8 | 105 | 2 | 19683999 | |
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 2.50e-04 | 8 | 105 | 2 | 21165971 | |
| Interaction | TRIM36 interactions | 7.50e-07 | 144 | 103 | 8 | int:TRIM36 | |
| Interaction | YWHAH interactions | IRS4 CNTRL GTSE1 CAMSAP3 APC INPP5F GLCCI1 DENND4C PYHIN1 SYNE2 OTUD7A KCNMA1 RAB11FIP5 ANKRD17 TANC1 CAMSAP1 CAMSAP2 ARHGAP21 WNK3 | 2.76e-06 | 1102 | 103 | 19 | int:YWHAH |
| Interaction | YWHAZ interactions | NCAPD3 IRS4 CAMSAP3 APC INPP5F GLCCI1 DENND4C FSIP2 NCOR1 ZNF644 SYNE2 KCNMA1 KCNK5 RAB11FIP5 ANKRD17 KATNIP TANC1 CAMSAP1 CAMSAP2 ARHGAP21 | 9.98e-06 | 1319 | 103 | 20 | int:YWHAZ |
| Interaction | YWHAQ interactions | IRS4 GTSE1 CAMSAP3 APC INPP5F GLCCI1 RNF43 DENND4C OTUD7A H1-6 KCNMA1 TMPO ANKRD17 TANC1 HADHA CAMSAP1 CAMSAP2 ARHGAP21 | 1.34e-05 | 1118 | 103 | 18 | int:YWHAQ |
| Interaction | NIN interactions | CNTRL GTSE1 UTP14A CAMSAP3 APC CCNB1 TANC1 CAMSAP1 CAMSAP2 ARHGAP21 | 1.54e-05 | 359 | 103 | 10 | int:NIN |
| Interaction | NINL interactions | NCAPD3 IRS4 KAT5 GTSE1 UTP14A CAMSAP3 NCOR1 TANC1 CAMSAP1 CAMSAP2 ARHGAP21 | 2.26e-05 | 458 | 103 | 11 | int:NINL |
| Interaction | CAMSAP2 interactions | 2.60e-05 | 169 | 103 | 7 | int:CAMSAP2 | |
| Interaction | DVL2 interactions | ELOA2 APC CDH23 ATP9B REV3L RNF43 CCNB1 BLM VANGL1 RAB11FIP5 TANC1 CEP19 | 2.74e-05 | 557 | 103 | 12 | int:DVL2 |
| Interaction | KCNA3 interactions | IRS4 SYTL2 DOLK APC FARSB ADCY9 DENND4C PRDM2 VANGL1 TMPO RAB11FIP5 ANKRD17 HADHA CAMSAP1 ARHGAP21 | 3.56e-05 | 871 | 103 | 15 | int:KCNA3 |
| Interaction | HDAC1 interactions | SFMBT1 IRS4 KAT5 CAMSAP3 APC INPP5F DENND4C CCNB1 RYBP BPTF NCOR1 ZZZ3 CCDC71 SYNE2 ANKRD17 CAMSAP1 ARHGAP21 | 4.41e-05 | 1108 | 103 | 17 | int:HDAC1 |
| Interaction | RABL6 interactions | 5.50e-05 | 130 | 103 | 6 | int:RABL6 | |
| Interaction | YWHAG interactions | IRS4 KAT5 GTSE1 CAMSAP3 APC INPP5F GLCCI1 DENND4C PYHIN1 SYNE2 OTUD7A KCNMA1 RAB11FIP5 ANKRD17 TANC1 CAMSAP1 CAMSAP2 ARHGAP21 | 5.72e-05 | 1248 | 103 | 18 | int:YWHAG |
| Interaction | RALBP1 interactions | 7.10e-05 | 198 | 103 | 7 | int:RALBP1 | |
| Interaction | RRM1 interactions | 8.64e-05 | 141 | 103 | 6 | int:RRM1 | |
| Interaction | ZNF138 interactions | 1.18e-04 | 19 | 103 | 3 | int:ZNF138 | |
| Interaction | NR3C1 interactions | NCAPD3 ELOA2 KAT5 MYO7A FARSB REV3L MEPE ANKRD36B NCOR1 ATXN7 SYNE2 RAB11FIP5 ANKRD17 HADHA CTNND2 | 1.25e-04 | 974 | 103 | 15 | int:NR3C1 |
| Interaction | KALRN interactions | 1.34e-04 | 96 | 103 | 5 | int:KALRN | |
| Interaction | CEP128 interactions | 1.43e-04 | 297 | 103 | 8 | int:CEP128 | |
| GeneFamily | Ankyrin repeat domain containing | 2.51e-04 | 242 | 66 | 6 | 403 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.19e-04 | 181 | 66 | 5 | 694 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 8.06e-04 | 50 | 66 | 3 | 721 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | CACNA1A ARHGAP24 MYO7A SYTL2 APC REV3L DSCAML1 PRDM2 ANKRD36B HIVEP3 FSIP2 KCNMA1 FAM217B CTNND2 CAMSAP2 WNK3 SEZ6L | 1.41e-06 | 1106 | 103 | 17 | M39071 |
| Coexpression | GABRIELY_MIR21_TARGETS | 2.16e-06 | 289 | 103 | 9 | M2196 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 9.00e-06 | 71 | 103 | 5 | M9544 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 2.43e-05 | 87 | 103 | 5 | MM851 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SFMBT1 APC INPP5F REV3L ADCY9 BLM RYBP BPTF ZZZ3 SYNE2 ANKRD17 EMC2 CAMSAP2 | 3.12e-05 | 856 | 103 | 13 | M4500 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 5.07e-05 | 166 | 103 | 6 | M6826 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_500 | 8.03e-07 | 156 | 101 | 8 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_500 | SFMBT1 ARHGAP24 RNF168 CNTRL APC REV3L RNF43 ERCC6L2 CRYBG1 CTNND2 CAMSAP2 | 3.71e-06 | 406 | 101 | 11 | gudmap_developingKidney_e15.5_ureter tip_500_flank cortic collct |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000 | SFMBT1 NCAPD3 ARHGAP24 RNF168 CNTRL APC REV3L RNF43 GTF2E1 FGD4 ERCC6L2 CRYBG1 CTNND2 CAMSAP2 | 2.58e-05 | 801 | 101 | 14 | gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | SFMBT1 NCAPD3 ARHGAP24 RNF168 CNTRL APC REV3L ERCC6L2 CAMSAP2 | 3.49e-05 | 339 | 101 | 9 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 4.98e-05 | 201 | 101 | 7 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_100 | 6.77e-05 | 17 | 101 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100_k2 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | CACNB2 CAMSAP3 CDH23 INPP5F REV3L RNF43 DENND4C LHCGR FGD4 GM2A HADHA ARHGAP21 WNK3 | 1.13e-04 | 804 | 101 | 13 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.46e-08 | 199 | 105 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.69e-07 | 192 | 105 | 7 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 4.70e-07 | 199 | 105 | 7 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | severe_influenza-gd_T|World / disease group, cell group and cell class (v2) | 3.04e-06 | 169 | 105 | 6 | 6d514dd2d1e5253bce49279f43aa2fa2b7c2653e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.25e-06 | 171 | 105 | 6 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | mild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2) | 3.48e-06 | 173 | 105 | 6 | b6615ff02f5017d7150b1e33b53f8c7a26081a0d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 5.12e-06 | 185 | 105 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.61e-06 | 188 | 105 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Lymphoid-T|Control / Disease state, Lineage and Cell class | 6.52e-06 | 193 | 105 | 6 | af928046ccd1ca874be1534aef6ca7f27d90bc46 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.92e-06 | 195 | 105 | 6 | 42382653e977714bff453bece26a6cd66ea2cc1f | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 7.12e-06 | 196 | 105 | 6 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.12e-06 | 196 | 105 | 6 | 51c750a0fb2b87e17e62b984c91fb16f676d7e76 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.33e-06 | 197 | 105 | 6 | 35004d4728d33f15cc3be99a073b1ea965365c32 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 7.55e-06 | 198 | 105 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 7.77e-06 | 199 | 105 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 7.77e-06 | 199 | 105 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.77e-06 | 199 | 105 | 6 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.99e-06 | 200 | 105 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.84e-05 | 137 | 105 | 5 | 761cc0e2b4971e98f6d0691d4575b5cd208b602d | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 3.43e-05 | 156 | 105 | 5 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-05 | 157 | 105 | 5 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 4.11e-05 | 162 | 105 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.88e-05 | 168 | 105 | 5 | b94b1f37c92e019d01ecfa3b7cc6797b6e4a56ff | |
| ToppCell | Influenza_Severe-gd_T|Influenza_Severe / Disease group and Cell class | 5.17e-05 | 170 | 105 | 5 | 59009c5a504ea8c6b4f6697299db219fd5edf7d6 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.31e-05 | 171 | 105 | 5 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 5.61e-05 | 173 | 105 | 5 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.77e-05 | 174 | 105 | 5 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.93e-05 | 175 | 105 | 5 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.60e-05 | 179 | 105 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.77e-05 | 180 | 105 | 5 | 401df9cddcbca1eb8f0d2687bcacd98e95dc1493 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 181 | 105 | 5 | b203b616584cdbd0bbb0e382b2916d0bd49d3526 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-05 | 181 | 105 | 5 | c748c16fd20d1949d33ff6290dc9d9016c4dc86c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.95e-05 | 181 | 105 | 5 | 5cecbafc29cc95896e6ccb2c74d9237b9aaece69 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.14e-05 | 182 | 105 | 5 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | severe_influenza-gd_T|severe_influenza / disease group, cell group and cell class (v2) | 7.14e-05 | 182 | 105 | 5 | b6b44c90af3f0c0dddb2b171087865d8c15a3973 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.14e-05 | 182 | 105 | 5 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 7.32e-05 | 183 | 105 | 5 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.32e-05 | 183 | 105 | 5 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 7.51e-05 | 184 | 105 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | COVID-19_Moderate-NK_activated|World / disease group, cell group and cell class | 7.91e-05 | 186 | 105 | 5 | ff8f32f69516bf785224fa12f8139a95359b0279 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.91e-05 | 186 | 105 | 5 | bbcd9062c0f6f65ca6f3cb101b6fa72ddd1e14fe | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.91e-05 | 186 | 105 | 5 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_activated|COVID-19_Severe / Disease group, lineage and cell class | 8.11e-05 | 187 | 105 | 5 | 4c4c4406e16a15dedcd50bbcc2059d722a2e3d2c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.11e-05 | 187 | 105 | 5 | cfdc1585c80d2bb475d9145395fb50a88c53f838 | |
| ToppCell | human_hepatoblastoma-NK.T_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 8.32e-05 | 188 | 105 | 5 | 71b7599e7e1d63cc0c8518c0501533755951d58f | |
| ToppCell | ASK452-Immune-T_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.53e-05 | 189 | 105 | 5 | f5dc500f77f04a110dd4a65cf4c03068a495dbdb | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 189 | 105 | 5 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.53e-05 | 189 | 105 | 5 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.74e-05 | 190 | 105 | 5 | b9182c84e44aa31684b5388cf3ef4fd1b9e51de4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.74e-05 | 190 | 105 | 5 | 88c092a5e78ccaddf406f8fff74376bb761b9790 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.74e-05 | 190 | 105 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.74e-05 | 190 | 105 | 5 | 4b42a16902d7d1494f953cc88af1e761e76bdf2c | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|IPF / Disease state, Lineage and Cell class | 8.74e-05 | 190 | 105 | 5 | e5d0186bfb416a3eda76ac12b9379650afb6f409 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T_activated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.74e-05 | 190 | 105 | 5 | 9501f0995f3d52be90c02b1aa0c7d184bd788c16 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.74e-05 | 190 | 105 | 5 | 66d29f53f129fc18771f6214316a913eeaccd55e | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.74e-05 | 190 | 105 | 5 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.96e-05 | 191 | 105 | 5 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.96e-05 | 191 | 105 | 5 | f3158cedf67e3b90aa94ea1f61c72c33aaa2d5ba | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 192 | 105 | 5 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | COPD-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 9.18e-05 | 192 | 105 | 5 | 5bfd9f5d47511441eb2d3cc3c4d7ed330ffd0bd1 | |
| ToppCell | COPD-Lymphoid-T|World / Disease state, Lineage and Cell class | 9.18e-05 | 192 | 105 | 5 | eb4909574fb5fc91399463523e2737095773200a | |
| ToppCell | Healthy_Control-Lymphoid-T-CD8_T|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.18e-05 | 192 | 105 | 5 | 36b6ea21b0b1342f2dcac4dcaf359b6c772203f7 | |
| ToppCell | COPD-Lymphoid|COPD / Disease state, Lineage and Cell class | 9.18e-05 | 192 | 105 | 5 | 064fefb8212fadab0ff441f4bf643559b7fdb25d | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 9.18e-05 | 192 | 105 | 5 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 192 | 105 | 5 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | IPF-Lymphoid-T|World / Disease state, Lineage and Cell class | 9.18e-05 | 192 | 105 | 5 | b25ba1f3bc842c22602b2aeed3b1b5082863e4fa | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 192 | 105 | 5 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|World / disease group, cell group and cell class | 9.41e-05 | 193 | 105 | 5 | ddc1db516568e03be8e82b2ca770c67756418185 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.41e-05 | 193 | 105 | 5 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | IPF-Lymphoid-T_Cytotoxic|World / Disease state, Lineage and Cell class | 9.41e-05 | 193 | 105 | 5 | 35c902a983d7f1156a74fe68ee366609029833b3 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.41e-05 | 193 | 105 | 5 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.64e-05 | 194 | 105 | 5 | e72be6dc2711c1d4f16943c8615cf9dc2e961ff3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.64e-05 | 194 | 105 | 5 | ac03be73fdc32dacd4a450c0fb28617e043b8444 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.64e-05 | 194 | 105 | 5 | 7ab4418a8a12c488d74af3676bdac672628da80c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.64e-05 | 194 | 105 | 5 | 0fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f | |
| ToppCell | human_hepatoblastoma-NK.T_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 9.64e-05 | 194 | 105 | 5 | 997b02a22d7c89a8fd5615bb79a2a8a34fc3fee6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_Tem-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.64e-05 | 194 | 105 | 5 | 760761ce7d22edf9a8cec71e8ab0caa273fce3f7 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | d77423d0ec64b397c6d1eec181c5fc0acaa92d63 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.87e-05 | 195 | 105 | 5 | 662b50a2aa97373bf343b88caace9717049c722a | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 9.87e-05 | 195 | 105 | 5 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.87e-05 | 195 | 105 | 5 | 9b7157b5e4b81bc35b0e6d9b954279160ea57324 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | f5bf4797972185afa76638293166abd536e5472f | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 9.87e-05 | 195 | 105 | 5 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.87e-05 | 195 | 105 | 5 | 14a6466524c22920daa622fbc710daf1defb46c3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.01e-04 | 196 | 105 | 5 | 60f5deb97f3d6f8422bb5849778205a7022002ae | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.04e-04 | 197 | 105 | 5 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | mLN-T_cell-Treg|T_cell / Region, Cell class and subclass | 1.04e-04 | 197 | 105 | 5 | 3779489d57ebda33277c79cba037f4c73128c8ba | |
| ToppCell | mild_COVID-19_(asymptomatic)-CD8+_Tem|World / disease group, cell group and cell class (v2) | 1.04e-04 | 197 | 105 | 5 | bdd212ea869d7c96e2ab29fa5145417afe83f2a9 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.04e-04 | 197 | 105 | 5 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-gd_T|URO / Disease, condition lineage and cell class | 1.06e-04 | 198 | 105 | 5 | cb584f7754ef4e6d9ec7155022852f2d2676ab4f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.06e-04 | 198 | 105 | 5 | a6b942fe850e287e1cb705684e29218072daf891 | |
| ToppCell | Severe-B_intermediate-10|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.06e-04 | 198 | 105 | 5 | dfae26c3513a82bb7cb8dadbfcea2a1f420b1bab | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 1.09e-04 | 199 | 105 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 1.09e-04 | 199 | 105 | 5 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-T/NK-gd_T|Influenza_Severe / Disease, condition lineage and cell class | 1.09e-04 | 199 | 105 | 5 | b1ecc8aa5a98fe42d678ab07b310d62ebaacdecf | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|COVID-19 / Condition, Lineage and Cell class | 1.09e-04 | 199 | 105 | 5 | e1dfc856a85a91e8f7ab8d600a8a891d16b2aefb | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Dendritic_cell-DC_activated|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-04 | 199 | 105 | 5 | 3b2bd3caf4d189a1726a737b0121860b265eec04 | |
| ToppCell | COVID-19_Severe-CD8+_T_activated|COVID-19_Severe / disease group, cell group and cell class | 1.09e-04 | 199 | 105 | 5 | a16b961996291bd5958c3851b7fdd7b45c53e19b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.09e-04 | 199 | 105 | 5 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.11e-04 | 200 | 105 | 5 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.52e-06 | 180 | 102 | 8 | 1793_DN | |
| Drug | tyrphostin AG-825; Down 200; 25.2uM; MCF7; HT_HG-U133A_EA | 1.87e-06 | 185 | 102 | 8 | 1114_DN | |
| Disease | Colorectal Carcinoma | CACNB2 IRS4 ELOA2 APC DSCAML1 RNF43 HIVEP3 ZZZ3 XAF1 CTNND2 CAMSAP2 | 3.84e-05 | 702 | 104 | 11 | C0009402 |
| Disease | Usher syndrome, type 1A | 1.22e-04 | 5 | 104 | 2 | C2931205 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 1.22e-04 | 5 | 104 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 1.22e-04 | 5 | 104 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 1.22e-04 | 5 | 104 | 2 | C1848640 | |
| Disease | Usher syndrome type 1 | 1.22e-04 | 5 | 104 | 2 | cv:C1568247 | |
| Disease | renal overload-type gout | 1.83e-04 | 6 | 104 | 2 | EFO_0021525 | |
| Disease | Usher Syndrome, Type I | 1.83e-04 | 6 | 104 | 2 | C1568247 | |
| Disease | Hereditary retinal dystrophy | 2.55e-04 | 7 | 104 | 2 | C0154860 | |
| Disease | Usher syndrome | 2.55e-04 | 7 | 104 | 2 | cv:C0271097 | |
| Disease | eosinophil cationic protein measurement | 3.40e-04 | 8 | 104 | 2 | EFO_0010913 | |
| Disease | longitudinal alcohol consumption measurement | 4.36e-04 | 9 | 104 | 2 | EFO_0007645 | |
| Disease | alpha fetoprotein measurement | 4.40e-04 | 100 | 104 | 4 | EFO_0010583 | |
| Disease | Benign tumor of pancreas | 9.36e-04 | 13 | 104 | 2 | C0347284 | |
| Disease | egg allergy measurement, parental genotype effect measurement | 9.36e-04 | 13 | 104 | 2 | EFO_0005939, EFO_0007018 | |
| Disease | amygdala volume change measurement | 1.43e-03 | 16 | 104 | 2 | EFO_0021490 | |
| Disease | basophil count, eosinophil count | 1.66e-03 | 241 | 104 | 5 | EFO_0004842, EFO_0005090 | |
| Disease | Pancreatic carcinoma | 2.02e-03 | 19 | 104 | 2 | C0235974 | |
| Disease | polycystic ovary syndrome (biomarker_via_orthology) | 2.47e-03 | 21 | 104 | 2 | DOID:11612 (biomarker_via_orthology) | |
| Disease | cholangiocarcinoma (is_implicated_in) | 2.71e-03 | 22 | 104 | 2 | DOID:4947 (is_implicated_in) | |
| Disease | Glioblastoma | 2.77e-03 | 79 | 104 | 3 | C0017636 | |
| Disease | psoriasis | 2.85e-03 | 273 | 104 | 5 | EFO_0000676 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 2.97e-03 | 23 | 104 | 2 | OBA_2045181 | |
| Disease | Giant Cell Glioblastoma | 3.30e-03 | 84 | 104 | 3 | C0334588 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NPNLLTASKFRAAKH | 291 | Q8TAA9 | |
| GTQTNSAKTARKPDH | 1151 | O00555 | |
| ALKSAAAATQRKAPS | 281 | Q10588 | |
| QQKIFSKAKIPSSSH | 6 | Q7Z7A1 | |
| SNKPHKAASSRISKT | 551 | A6NCI8 | |
| TRAAEQLKNNPRHKS | 46 | Q96LK0 | |
| SSTKAKGHNPRSSIA | 266 | P35368 | |
| QSSRHSKEKDRQSPL | 246 | Q86VQ1 | |
| RVSSHKQPSLKATSD | 526 | Q8N2N9 | |
| KHFSPIKQSTTLTNK | 121 | Q9H9E1 | |
| NKAASKQKSSSHLPA | 776 | O75179 | |
| KQKSSSHLPANSQDV | 781 | O75179 | |
| KSALHSSVPKSTNDR | 1376 | Q12830 | |
| SSKSNKPIIHNAISH | 1471 | Q5T5Y3 | |
| PSAKSNKFIIHNALS | 1116 | Q9P1Y5 | |
| NARTESAKSTPLHKL | 3326 | Q9H251 | |
| HSPKVVKAASQVLNS | 1001 | Q9UQB3 | |
| PNASQATTRTTRKKA | 151 | Q6NXP0 | |
| SLAKRSVLNNPSKHA | 326 | Q08289 | |
| RDSAQSPKLFTHKRT | 291 | Q9BXF6 | |
| SQRPLKHETSTVQKS | 441 | Q9UPP5 | |
| RRVSSHKQPALKATS | 951 | Q5JPF3 | |
| SSNEHAAPAAKTRKQ | 716 | Q8IYF1 | |
| NKPSQSTLKLSTLHC | 671 | P22888 | |
| KRSSSESKKHQAPTI | 321 | Q9UPQ8 | |
| KKSSSVHSIPSTANR | 1201 | Q12791 | |
| HISDQSPLSSKRKAL | 346 | P42166 | |
| SNKSHKVKSSQQPAA | 116 | Q96IV0 | |
| SQAQKSPVKSKSTHR | 201 | Q9NQ76 | |
| AQHADTSVKPQALKS | 206 | Q69YI7 | |
| HVVRQQQSSSLPSKK | 831 | Q86Z02 | |
| ANSELKSSPRKAIHS | 76 | O60303 | |
| NTKERPQRATTKVHS | 821 | O60303 | |
| SDNHKGNSTLSVPKR | 451 | Q9NUN5 | |
| AQSSAPKVRKSVSSR | 526 | O43861 | |
| TNKRTSKSSLHRPLD | 1521 | Q2LD37 | |
| SSSCLQPNHRSTKRK | 136 | Q92993 | |
| SAAPLDQNKKRSSSI | 986 | Q5VZ46 | |
| AHQRSISLSSRKPKS | 1371 | Q5CZC0 | |
| PHSRKALQVKGSTAS | 271 | O95279 | |
| ITIKNHSPTGQSKAR | 226 | Q8NGC6 | |
| SSGKRQSKSQVPHAS | 16 | Q9NTX9 | |
| RSADLPHSFKLTQSK | 701 | Q96M96 | |
| SEKHRLPVSLSSAKQ | 136 | O95750 | |
| NKHTLPLASAASKIS | 636 | Q9P1Y6 | |
| LKLASSEPRTHFSKN | 271 | Q8TE49 | |
| KRKNSSPLLVHSSSS | 706 | O15265 | |
| HAASQAATQRKPGTK | 201 | Q9NYZ3 | |
| SGSKTNSPKNSVHKL | 396 | Q8N264 | |
| NSPKNSVHKLDVSRS | 401 | Q8N264 | |
| SLNKKSRSSTPVHNS | 121 | Q96QU4 | |
| AKASTPALAKHATTN | 126 | Q8IV32 | |
| TSKHAKISTLPQLNS | 406 | P14635 | |
| SPVKARASKSKLTQH | 181 | P22492 | |
| HSARTLNNKLSLSKP | 16 | P54132 | |
| TNPVSRKNVKSAHST | 1726 | Q8TD84 | |
| LLSDKPQSHQRTKRS | 46 | Q9HBT6 | |
| KPLANRHATASKNIF | 196 | Q6K0P9 | |
| KQQTPSRTHKERSTS | 1311 | Q5VZ89 | |
| NSVKRHATSSPKNRK | 356 | O60503 | |
| DSSTQAKDAHLSPKR | 1296 | O60503 | |
| QTHPSLASQGSKKSK | 131 | Q99750 | |
| SPNSKVNTLSKELHS | 56 | P40939 | |
| TQKVPSKRQHSSVSS | 126 | Q00978 | |
| ASHIASNPKASAKTK | 236 | Q15006 | |
| SQPVHKGNTATKISL | 261 | Q9Y4K1 | |
| SFSSKLPSHNKKNST | 1081 | Q5T890 | |
| LKTFTHIKSNVSAPN | 131 | Q9Y2H2 | |
| SDRKQFSHIPAKTLS | 1446 | Q08AD1 | |
| KPKAVAKNHSAQLSS | 1591 | Q13029 | |
| SSTQLKHRNAVQGSK | 26 | Q8N7B6 | |
| KHRNAVQGSKSSLST | 31 | Q8N7B6 | |
| APQNVSASKKRHSRS | 721 | O14654 | |
| AQAHLKKPSQLSSFS | 21 | P17900 | |
| IPALKQSKDHAATTA | 211 | P29083 | |
| LSRHKKSPSSLTNLS | 586 | Q9HCH5 | |
| NSARKQLRPKATSAA | 126 | Q9BYH1 | |
| TINHSKESKPTFSRA | 311 | Q96DU3 | |
| NTHVKTSNLAAPKSR | 611 | B4DYI2 | |
| HSPSSASQVKHLLQK | 5086 | Q8WXH0 | |
| NTHVKTSNLAAPKSG | 761 | Q5VVP1 | |
| KSTNHERKSTLTPTQ | 1511 | O75376 | |
| KTSETNHTSRPRLKN | 136 | Q8N488 | |
| NLQKSSLSARHPQRK | 641 | Q68DV7 | |
| GLTTHSNKTFTQRPK | 791 | Q9ULL8 | |
| PRQSHLVQSRVNKKS | 71 | Q9C0D5 | |
| SNNFTHSRAKLKCPS | 1376 | Q6P1J6 | |
| SNTHVKTSNLAAPKS | 616 | P0DKV0 | |
| ISATKAVHISNPKTA | 431 | Q9NSD9 | |
| IDNLSPKASHRSKQR | 776 | P25054 | |
| RKQALKFHPLVNASS | 401 | A6NFN9 | |
| KAPTVRSKALSSFAH | 456 | P42695 | |
| QKAVHKSPLSVRSTD | 271 | Q96PV4 | |
| SNETSSKAPCRKHTN | 151 | O00300 | |
| EHNKANKRTRSVTSP | 1566 | O60673 | |
| KNPSASKNVQSHRKA | 756 | Q9BX26 | |
| SINRFPLHSESSSKK | 216 | Q6GPH4 | |
| LARKHSLTKNDSSPQ | 1981 | Q5T1R4 | |
| HQSRKQKASSEGTIP | 471 | Q9BVJ6 | |
| VSKSAHSLQPSISQK | 546 | Q8IYW5 | |
| VSNSKLKRSSHLSLP | 111 | P85298 | |
| SAISPQKIHNQTARK | 1186 | Q9H582 | |
| RNKDNSTACSHPVTK | 586 | Q8IWR0 | |
| FKHKNQSPKTVASSL | 261 | Q9UL40 | |
| SSRTVGCPKQKSHRQ | 281 | Q9UDV6 | |
| VHKKKRSSASVDNTP | 676 | Q9UHJ3 | |
| VHSKPRTSKSIAKNS | 301 | Q9C0G0 | |
| VRSNSLKAPSTHVTK | 621 | Q5T5U3 | |
| QAKKLSRTQASSSPA | 976 | Q6BDS2 | |
| KSSTSRRQHPLNKHL | 726 | Q8IYH5 | |
| APASKTLTLHNSAKV | 261 | C9JJH3 | |
| SFKSKLRSRPQSLTH | 1591 | Q9BYP7 | |
| SKQLTHNPSKSSYAR | 1176 | Q13402 |